Hormone Therapy and the Risk of Breast Cancer in BRCA1 Mutation Carriers

BACKGROUND: Hormone therapy (HT) is commonly given to women to alleviate the climacteric symptoms associated with menopause. There is concern that this treatment may increase the risk of breast cancer. The potential association of HT and breast cancer risk is of particular interest to women who carr...

Descripción completa

Detalles Bibliográficos
Autores principales: Eisen, Andrea, Lubinski, Jan, Gronwald, Jacek, Moller, Pal, Lynch, Henry T., Klijn, Jan, Kim-Sing, Charmaine, Neuhausen, Susan L., Gilbert, Lucy, Ghadirian, Parviz, Manoukian, Siranoush, Rennert, Gad, Friedman, Eitan, Isaacs, Claudine, Rosen, Eliot, Rosen, Barry, Daly, Mary, Sun, Ping, Narod, Steven A.
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2008
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2556701/
https://www.ncbi.nlm.nih.gov/pubmed/18812548
http://dx.doi.org/10.1093/jnci/djn313

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2556701/
https://www.ncbi.nlm.nih.gov/pubmed/18812548
http://dx.doi.org/10.1093/jnci/djn313

Ejemplares similares